Avanos Medical, Inc. (NYSE:AVNS) is reporting third quarter financial results on Tuesday 3rd November 2020, before market open.
According to analysts surveyed by Thomson Reuters, AVNS is expected to report 3Q20 income of $ 0.10 per share from revenue of $ 165.87 million.
For the full year, analysts anticipate top line of $ 689.37 million, while looking forward to income of $ 0.56 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 732.48 million ~ $ 746.43 million, where as bottomline are predicted in a range of $ 1.00 ~ $ 1.20 per share
Click Here For More Historical Outlooks Of Avanos Medical, Inc.
Previous Quarter Performance
Avanos Medical, Inc. communicated income for the second quarter of $ 0.13 per share, from the revenue of $ 163.70 million. The quarterly earnings declined 53.57 percent while revenues down 4.72 percent compared with the same quarter last year.
The consensus estimates are loss of $ 0.10 per share from $ 147.90 million in revenue. The bottom line results beat street analysts by $ 0.23 or 230.00 percent, at the same time, top line results outshined analysts by $ 15.80 million or 10.68 percent.
Stock Performance
Shares of Avanos Medical, Inc. traded up $ 1.75 or 4.95 percent on Monday, reaching $ 37.10 with volume of 426.20 thousand shares. Avanos Medical, Inc. has traded high as $ 37.31 and has cracked $ 35.37 on the downward trend
The closing price of $ 37.10, representing a 81.65 % increase from the 52 week low of $ 19.46 and a 26.46 % decrease over the 52 week high of $ 48.07.
The company has a market capital of $ 1.77 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
Conference Call
Avanos Medical, Inc. will be hosting a conference call at 9:00 AM eastern time on 3rd November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website avanos.com
Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients quality of life worldwide. It provides a portfolio of products focuses on respiratory and digestive health; pain management solutions; and minimally invasive interventional pain therapies, closed airway suction systems, and enteral feeding tubes.
